J. P. Moreau

1.2k total citations
16 papers, 1.0k citations indexed

About

J. P. Moreau is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, J. P. Moreau has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Neurology. Recurrent topics in J. P. Moreau's work include Neuroendocrine Tumor Research Advances (9 papers), Pituitary Gland Disorders and Treatments (7 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). J. P. Moreau is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Pituitary Gland Disorders and Treatments (7 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). J. P. Moreau collaborates with scholars based in France, United States and Switzerland. J. P. Moreau's co-authors include Michael D. Culler, P Jaquet, Alexandru Saveanu, Ginette Gunz, A Enjalbert, L’Houcine Ouafik, J. E. Taylor, F.V. DeFeudis, Kei Yasuda and G I Bell and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

J. P. Moreau

14 papers receiving 981 citations

Peers

J. P. Moreau
J. P. Moreau
Citations per year, relative to J. P. Moreau J. P. Moreau (= 1×) peers Marica Arvigo

Countries citing papers authored by J. P. Moreau

Since Specialization
Citations

This map shows the geographic impact of J. P. Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Moreau more than expected).

Fields of papers citing papers by J. P. Moreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Moreau. The network helps show where J. P. Moreau may publish in the future.

Co-authorship network of co-authors of J. P. Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Moreau. A scholar is included among the top collaborators of J. P. Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Moreau. J. P. Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nardin, Charlée, et al.. (2015). Intérêt du lanréotide dans le traitement du carcinome de Merckel métastatique. Annales de Dermatologie et de Vénéréologie. 142(12). S522–S523.
3.
Jaquet, P, Ginette Gunz, Alexandru Saveanu, et al.. (2005). BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.. PubMed. 28(11 Suppl International). 21–7. 59 indexed citations
4.
Culler, Michael D., J.E. Taylor, & J. P. Moreau. (2002). Somatostatin receptor subtypes: targeting functional and therapeutic specificity.. PubMed. 63(2 Pt 3). 2S5–12. 16 indexed citations
5.
Saveanu, Alexandru, Ginette Gunz, Henry Dufour, et al.. (2001). BIM-23244, a Somatostatin Receptor Subtype 2- and 5-Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-Resistant Human GH-Secreting Adenomas1. The Journal of Clinical Endocrinology & Metabolism. 86(1). 140–145. 153 indexed citations
6.
Jaquet, P, Alexandru Saveanu, Ginette Gunz, et al.. (2000). Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral Phenotypes1. The Journal of Clinical Endocrinology & Metabolism. 85(2). 781–792. 139 indexed citations
7.
Jaquet, P, L’Houcine Ouafik, Alexandru Saveanu, et al.. (1999). Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas1. The Journal of Clinical Endocrinology & Metabolism. 84(9). 3268–3276. 96 indexed citations
8.
Moreau, J. P., et al.. (1997). Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. British Journal of Cancer. 75(7). 1021–1027. 70 indexed citations
9.
Raynor, K, William A. Murphy, D.H. Coy, et al.. (1993). Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.. Molecular Pharmacology. 43(6). 838–844. 244 indexed citations
10.
Taylor, J. E., F.V. DeFeudis, & J. P. Moreau. (1989). Bradykinin‐antagonists: Therapeutic perspectives. Drug Development Research. 16(1). 1–11. 28 indexed citations
11.
Coy, D.H., Peter Heinz‐Erian, John Taylor, et al.. (1988). Progress in the Development of Competitive Bombesin Antagonists. Annals of the New York Academy of Sciences. 547(1). 150–157. 5 indexed citations
12.
Taylor, John E., D.H. Coy, & J. P. Moreau. (1988). High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). Life Sciences. 43(5). 421–427. 32 indexed citations
13.
Moreau, J. P. & F.V. DeFeudis. (1987). Pharmacological studies of somatostatin and somatostatin-analogues: Therapeutic advances and perspectives. Life Sciences. 40(5). 419–437. 52 indexed citations
14.
Moreau, J. P., et al.. (1975). Therapeutic activity of levamisole in Bancroftian filariasis. A follow-up control of microfilaraemia during 45 days after 12 days' treatment.. 35(6). 451–455. 1 indexed citations
15.
Moreau, J. P., et al.. (1972). Survie in vitro des larves de troisième stade d’Angiostrongylus cantonensis. Annales de Parasitologie Humaine et Comparée. 47(4). 525–529. 4 indexed citations
16.
Moreau, J. P., et al.. (1972). [In vitro trials of diethylcarbamazine. I. Effect on microfilariae of Wuchereria bancrofti var. pacifica].. PubMed. 65(1). 93–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026